Pharmacokinetic study of high-dose oral rifampicin in critically Ill patients with multidrug-resistant Acinetobacter baumannii infection

被引：0
|
作者：
Hossein Karballaei-Mirzahosseini
Romina Kaveh-Ahangaran
Bita Shahrami
Mohammad Reza Rouini
Atabak Najafi
Arezoo Ahmadi
Sima Sadrai
Amirmahdi Mojtahedzadeh
Farhad Najmeddin
Mojtaba Mojtahedzadeh
机构：
[1] Tehran University of Medical Sciences,Department of Clinical Pharmacy, School of Pharmacy
[2] Tehran University of Medical Sciences,Department of Pharmaceutics, School of Pharmacy
[3] Tehran University of Medical Sciences,Department of Anesthesiology and Critical Care, School of Medicine
[4] Semmelweis University,Faculty of Medicine
[5] Tehran University of Medical Sciences,Research Center for Rational Use of Drugs
来源：
DARU Journal of Pharmaceutical Sciences | 2022年 / 30卷
关键词：
Rifampin; Gram-negative Bacilli Infection; Critical Illness; Sepsis; Antimicrobial Resistance; Carbapenem-resistant Acinetobacter Baumanni;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：311 / 322
页数：11
相关论文
共 50 条
  • [31] Genome dynamics of multidrug-resistant Acinetobacter baumannii during infection and treatment
    Meredith S. Wright
    Alina Iovleva
    Michael R. Jacobs
    Robert A. Bonomo
    Mark D. Adams
    Genome Medicine, 8
  • [32] Multidrug-Resistant Acinetobacter baumannii May Cause Patients to Develop Polymicrobial Bloodstream Infection
    Chen, Qingqing
    Zheng, Zhencang
    Shi, Qingxin
    Wu, Huijuan
    Li, Yuping
    Zheng, Cheng
    CANADIAN JOURNAL OF INFECTIOUS DISEASES & MEDICAL MICROBIOLOGY, 2022, 2022
  • [33] Multidrug-resistant Acinetobacter baumannii prosthetic joint infection treated with colistin
    Guardado, A. Rodriguez
    Asensi, V.
    Lantero, M.
    Castillo, M.
    Carton, J.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 29 : S372 - S372
  • [34] Case Commentary: Novel Therapy for Multidrug-Resistant Acinetobacter baumannii Infection
    Eales, Brianna M.
    Tam, Vincent H.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2022, 66 (01)
  • [35] Clinical Outcomes of Tigecycline in the Treatment of Multidrug-Resistant Acinetobacter baumannii Infection
    Shin, Jung Ar
    Chang, Yoon Soo
    Kim, Hyung Jung
    Kim, Se Kyu
    Chang, Joon
    Ahn, Chul Min
    Byun, Min Kwang
    YONSEI MEDICAL JOURNAL, 2012, 53 (05) : 974 - 984
  • [36] Genome dynamics of multidrug-resistant Acinetobacter baumannii during infection and treatment
    Wright, Meredith S.
    Iovleva, Alina
    Jacobs, Michael R.
    Bonomo, Robert A.
    Adams, Mark D.
    GENOME MEDICINE, 2016, 8
  • [37] Outcomes of Acinetobacter baumannii infection in critically ill burned patients
    Trottier, Vincent
    Gonzalez Segura, Penelope
    Namias, Nicholas
    King, David
    Pizano, Louis R.
    Schulman, Carl I.
    JOURNAL OF BURN CARE & RESEARCH, 2007, 28 (02): : 248 - 254
  • [38] Model-informed dose optimisation of polymyxin-rifampicin combination therapy against multidrug-resistant Acinetobacter baumannii
    Zhao, Jinxin
    Zhu, Yan
    Han, Mei-Ling
    Lu, Jing
    Yu, Heidi H.
    Wickremasinghe, Hasini
    Zhou, Qi Tony
    Bergen, Phillip
    Rao, Gauri
    Velkov, Tony
    Lin, Yu-Wei
    Li, Jian
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2023, 62 (03)
  • [39] Colistin offers prolonged survival in experimental infection by multidrug-resistant Acinetobacter baumannii:: the significance of co-administration of rifampicin
    Pantopoulou, Alkistis
    Giamarellos-Bourboulis, Evangelos J.
    Raftogannis, Maria
    Tsaganos, Thomas
    Dontas, Ismini
    Koutoukas, Pantelis
    Baziaka, Fotini
    Giamarellou, Helen
    Perrea, Despina
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 29 (01) : 51 - 55
  • [40] Polymyxin dose tunes the evolutionary dynamics of resistance in multidrug-resistant Acinetobacter baumannii
    Zhao, Jinxin
    Zhu, Yan
    Lin, Yu-Wei
    Yu, Heidi
    Wickremasinghe, Hasini
    Han, Jiru
    Velkov, Tony
    McDonald, Michael J.
    Li, Jian
    CLINICAL MICROBIOLOGY AND INFECTION, 2022, 28 (07) : 1026.e1 - 1026.e5
12345